Hastalık Maliyet Analizinin Bibliyometrik ve Doküman Açısından İncelemesi

Abstract

Amaç: Bu çalışmanın temel amacı, hastalık maliyeti analizini odağına alan çalışmaları en çok atıf alma şartına bağlı olarak incelemektir.

Gereç ve Yöntem: Bu çalışmada yöntem olarak iki teknikten (bibliyometrik ve doküman analizi) yararlanılmaktadır. Bu doğrultuda Web of Science Core Collection veri tabanından 1975-2017 yılları arasını kapsayan “cost of illness”, “cost of disease” ve “economic burden of” kavramlarıyla ilgili çalışmalar derlenmiştir.

Bulgular: Hastalık maliyet analizi ile ilgili yapılan çalışmalara ülkeler bazında bakıldığında en fazla yayın yapan ülke ABD’dir. En fazla atfa sahip olan yazarlar ise Boncz, I. ve Baser, O.’dur. Dagenais ve ark.’nın (2008), Brown’un (2003) ve Burge ve ark. (2007) çalışması “cost of illness”, “cost of disease” ve “economic burden of” kavramları en çok atıf alan çalışmalardır.

Sonuç: Yapılan bu çalışma, hastalık maliyet analizi konusunda bundan sonra yapılacak çalışmalara yol gösterir niteliktedir. Hastalık maliyeti alanında çalışma yapmak isteyen araştırmacılar konu hakkında en hızlı şekilde ilerleyebilmek için en çok atıf alan ilk on çalışmaya başvurmalıdır.

Keywords

• Hastalık Maliyet Analizi,Ekonomik Yük,Bakış Açısı

Investigation Terms of Biliometric and Document of Disease Cost Analysis

Abstract

Objective: The main purpose of this study is to examine according to the condition of citation the studies that focus on the analysis of disease cost.

Methods: In this study, the method of two techniques (bibliometnc and document analysis) was used. In this direction, were compiled studies on the concepts of "cost of illness", "cost of disease" and "economic burden of" between 1975-2017 were compiled from Web of Science Core Collection database.

Results: When examined in terms of countries to studies on disease cost analysis, the top publishing country is the US. The writers who have the most cited Boncza, I. et Base is O. Dagenais et al. (2008), Brown (2003) and Burge et al. (2007) study, the concepts of "cost of illness", "cost of disease" and "economic burden of" are the most cited studies.

Conclusion: This study will guide the future work on disease cost analysis.Researchers who want to work in the field of disease cost should apply to the top ten study that most cited for the fastest way to go forward on the issue.

Keywords

• Dısease cost analysıs,Economic burden,Perspective

References

1. 1. Ağırbaş, İ. Sağlık kurumlarında finansal yönetim ve maliyet analizi, Siyasal kitabevi Ankara 2014.
2. 2. Alp, E., Cevahir, F., Ersoy, S., Guney, A. Incidence and economic burden of prosthetic joint infections in a university hospital: a report from a middle-income country. Journal of infection and public health 2016; 9(4):494-498.
3. 3. Alp, E., Kalin, G., Coskun, R., Sungur, M., Guven, M., & Doganay, M. Economic burden of ventilator-associated pneumonia in a developing country. Journal of Hospital Infection 2012; 81(2):128-130.
4. 4. Ambrosy, A. P., Fonarow, G. C., Butler, J., Chioncel, O., Greene, S. J., Vaduganathan, M., Gheorghiade, M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. Journal of the American College of Cardiology 2014;63(12):1123-1133.
5. 5. Bavbek, S., Mungan, D., Türktaş, H., Mısırlıgil, Z., Gemicioğlu, B., & Advıse Study Group. A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey. Respiratory medicine 2011; 105(4):541-548.
6. 6. Benkovic, V., Kolcic, I., Uhernik, I. I., Krznaric, Z., Bender, D. V., Stevanovic, R. PGI12 Cost of Disease Related Malnutrition in Croatia–a Hidden Cost in the Health Care Closet Wants out. Value in Health 2012;15(7):A327.
7. 7. Borghouts, J. A., Koes, B. W., Vondeling, H., Bouter, L. M. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 1999;80(3):629-636.
8. 8. Bowen, G. A. Document analysis as a qualitative research method. Qualitative research journal 2009;9(2):27-40.

9. 9. Brown, J. K. A cost of disease resistance: paradigm or peculiarity?. Trends in Genetics 2003;19(12):667-671.
10. 10. Brown, M. G. Cost of disease-modifying therapies for multiple sclerosisAbout multiple sclerosis. Neurology 2015:84(21);181-185.
11. 11. Burge, R., Dawson‐Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025. Journal of bone and mineral research 2007;22(3): 465-475.
12. 12. ByfordS., Raftery, J. Economics notes: Perspectives in economic evaluation. BMJ: British Medical Journal 1998;316(7143):1529.
13. 13. ByfordS., Torgerson, D.J., Raftery, J. Economic note: cost of illness studies. BMJ( Clinical research ed.) 2000;320(7245);1335-1335.
14. 14. Cakir, B.Ö., Adamson, P., Cingi, C. Epidemiology and economic burden of nonmelanoma skin cancer. Facial plastic surgery clinics of North America 2012;20(4): 419-422.
15. 15. Corbin, J., & Strauss, A. Basics of qualitative research. London: Sage Publication Ltd. 2008.
16. 16. Dagenais, S., Caro, J., Haldeman, S. A systematic review of low back pain cost of illness studies in the United States and internationally. The spine journal 2008;8(1): 8-20.
17. 17. Deger, C., Ozdemir, O., Bozkurt, K., Demir, M., Ince, B., Kultursay, H., Ongen, G. Ongen, Z, Marmarali, B., Ozel, M.O., Parali, E., Sumer, F., Tuna, E., Yilmaz, Z.S. The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs. Value in Health 2013; 16(3):A281.
18. 18. Drummond, M. Cost-of-illness studies. Pharmacoeconomics 1992;2(1):1-4.
19. 19. Fendrick, A. M., Monto, A. S., Nightengale, B., & Sarnes, M. The economic burden of non–influenza-related viral respiratory tract infection in the United States. Archives of internal medicine 2003;163(4):487-494.
20. 20. Frerichs, R. R., Becht, J. N., Foxman, B. Prevalence and cost of illness episodes in rural Bolivia. International journal of epidemiology 1980;9(3):233-238.
21. 21. Gallup, J. L., & Sachs, J. D. The economic burden of malaria. The American journal of tropical medicine and hygiene 2001;64(1_suppl): 85-96.
22. 22. Gemmill, A. W., Read, A. F. Counting the cost of disease resistance. Trends in Ecology & Evolution 1998;13(1): 8-9.
23. 23. Gleizes, O., Desselberger, U., Tatochenko, V., Rodrigo, C., Salman, N., Mezner, Z., Giaquinto, C., Grimprel, E. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. The Pediatric infectious disease journal 2006;25(1): 12-21.
24. 24. Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., Corey-Lisle, P. K. The economic burden of depression in the United States: how did it change between 1990 and 2000?. Journal of clinical psychiatry 2003;64(12):1465-1475.
25. 25. Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Fyer, A. J. The economic burden of anxiety disorders in the 1990s. The Journal of Clinical Psychiatry 1999;60(7): 427-435.
26. 26. Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., & Berndt, E. R. The economic burden of depression in 1990. The Journal of clinical psychiatry 1993.
27. 27. Hodgson, T. A., Meiners, M. R. Cost-of-illness methodology: a guide to current practices and procedures. The Milbank Memorial Fund Quarterly. Health and Society 1982;429-462.
28. 28. Hodgson, T.A. The state of the art of cost-of-illness estimates. Advances in health ecomomics and health services research 1983;(4):129-164.
29. 29. Hoffmann, S., Batz, M. B., Morris Jr, J. G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. Journal of food protection 2012; 75(7):1292-1302.
30. 30. Johnson, J. A., Bootman, J. L. Drug-related morbidity and mortality: a cost of illness model 1995; (155): 1949-56.
31. 31. Kurtz, S. M., Lau, E., Watson, H., Schmier, J. K., & Parvizi, J. Economic burden of periprosthetic joint infection in the United States. The Journal of arthroplasty 2012; 27(8): 61-65.
32. 32. Leardini, G., Salaffi, F., Montanelli, R., Gerzeli, S., Canesi, B. A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clinical and experimental rheumatology 2002;20(4):505-516.
33. 33. Liljas, B. How to calculate indirect costs in Economic evaluations. Pharmacoeconomics 1998; 13(1):1-7.
34. 34. Liu, X.,Zhan, F. B., Hong, S., Niu, B., &Liu, Y. Repliestocomments on “a bibliometricstudy of earthquakeresearch: 1900–2010”. Scientometrics 2013;96(3):933-936.
35. 35. Malone, D. C., Lawson, K. A., Smith, D. H., Arrighi, H. M., Battista, C. A cost of illness study of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology 1997;99(1): 22-27.
36. 36. Meerding, W. J., Bonneux, L., Polder, J. J., Koopmanschap, M. A., van der Maas, P. J. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. Bmj 1998; 317(7151):111-115.
37. 37. Mustafa, G., Al Aidaroos, A. Y., Al Abaidani, I. S., Meszaros, K., Gopala, K., Ceyhan, M., ATannir, M., DeAntonio, R., Bawikar, S., Schmidt, J. E. Incidence and economic burden of acute otitis media in children aged up to 5 years in three Middle Eastern countries and Pakistan: A multinational, retrospective, observational study. Journal of epidemiology and global health 2017;7(2):123-130.
38. 38. Özgülbaş, N. Sağlık Sektöründe Hizmet ve Hastalık Maliyet Analizi. Siyasal Kitabevi, Ankara 2014.
39. 39. Öztürk, S., & Kilic, D. What is the economic burden of sports injuries. Eklem Hastalik Cerrahisi 2013; 24(2):108-11.
40. 40. Rentz, A. M., Halpern, M. T., Bowden, R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clinical Infectious Diseases, 1998:27(4); 781-788.
41. 41. Rice, D. P. Cost of illness studies: what is good about them?. Injury Prevention 2000;6(3):177-179.
42. 42. Sadeghi, B., Abolhassani, H., Naseri, A., Rezaei, N., & Aghamohammadi, A. Economic burden of common variable immunodeficiency: annual cost of disease. Expert review of clinical immunology 2015;11(5):681-688.
43. 43. Segel, J.E. Cost-of-illness studies - a primer. RTI-UNC Center of Excellence in Health Promotion Economics 2006; 1-39.
44. 44. Simoens, S., Hummelshoj, L., Dunselman, G., Brandes, I., Dirksen, C., D’Hooghe, T., Endocost Consortium. Endometriosis cost assessment (the endocost study): a cost-of-illness study protocol. Gynecologic and obstetric investigation 2011;71(3):170-176.
45. 45. Süt, N. Hastalık maliyet analizi. READ Dergisi 2012;4(1):24-28.
46. 46. Tarricone, R. Cost-of-illness analysis: what room in health economics?. Health Policy 2006;77(1):51-63.
47. 47. Van Den Akker‐van Marle, M. E., Bruil, J., & Detmar, S. B. Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union. Allergy 2005;60(2), 140-149.
48. 48. Van Tulder, M. W., Koes, B. W., Bouter, L. M. A cost-of-illness study of back pain in The Netherlands. Pain 1995;62(2):233-240.
49. 49. Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. Health and economic burden of the projected obesity trends in the USA and the UK. The Lancet 2011;378(9793): 815-825.
50. 50. Weiss, K. B., Sullivan, S. D., Lyttle, C. S. Trends in the cost of illness for asthma in the United States, 1985-1994. Journal of Allergy and Clinical Immunology 2000;106(3):493-499.
51. 51. Willich, S. N., Nocon, M., Kulig, M., Jaspersen, D., Labenz, J., Meyer‐Sabellek, W., Stolte, M., Lind, T., Malfertheiner, P. Cost‐of‐disease analysis in patients with gastro‐oesophageal reflux disease and Barrett's mucosa. Alimentary pharmacology & therapeutics 2006;23(3):371-376.